People living with diabetes are at a higher risk for stroke than those without diabetes. Recent evidence shows that certain drugs have demonstrated an ability to reduce the risk of stroke in individuals with type 2 diabetes.
This module will review data from cardiovascular outcome trials and meta-analyses, along with the recommendations from Diabetes Canada guidelines and the current Canadian Stroke Best Practice Recommendations, for the secondary prevention of stroke to help optimize care in this population.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.